Jorge Garcia, MD

216.444.6833

Jorge Garcia, MD
Department: Hematology and Oncology
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.444.7774
WorkFax:216.444.9464
Jorge Garcia, MD
Department: Urology
Location: Cleveland Clinic Main Campus
Mail Code R35
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.6833
DeskDesk:216.444.7774
WorkFax:216.444.9464
Surgeon:
No
Treats:
Adults Only

Education & Fellowships

Fellowship - University of California San Francisco Medical Center
Hematology/Medical Oncology
San Francisco, CA USA
2004
Fellowship - University of California San Francisco Medical Center
Urologic Oncology
San Francisco, CA USA
2004
Residency - Albert Einstein College of Medicine
Internal Medicine
New York, NY USA
2001
Internship - Albert Einstein College of Medicine
Internal Medicine
New York, NY USA
1999
Fellowship - Harvard Medical School
Cancer Biology
Boston, MA USA
1998
Medical School - Escuela Colombiana de Medicina
Santa Fe De Bogota Colombia
1994
Undergraduate - Calasanz College
Biology/Biochemistry
Santa Fe de Bogota Colombia

Certifications

  • Internal Medicine- Medical Oncology

Specialty Interests

Genitourinary malignancies, clinical trials, experimental therapeutics, adrenal cancer, bladder cancer, cancer, kidney cancer, prostate cancer, testicular cancer

Awards & Honors

  • "Best Doctor in America," 2009/2010
  • “Best Hispanic Leader,” Cuyahoga County, Ohio, 2006
  • Young Investigator Award, American Society of Clinical Oncology (ASCO), 2004
  • Methods in Clinical Cancer Research Award, ASCO/American Association of Cancer Research, 2003
  • Amgen Educational Award, University of California, San Francisco, 2002
  • Outstanding Resident Award, East Campus, Albert Einstein College of Medicine, 1999
  • Leo M. Davidoff Society Teaching Award, Albert Einstein College of Medicine, 1998
  • Fellow in FACP since 7/1/09 from the Ohio Chapter

Memberships

  • American Association for Cancer Research
  • American Society of Clinical Oncology
  • American College of Physicians
  • American Medical Association

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 2/11/2014, Dr. Garcia has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Garcia received fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Algeta, ASA
  • Astellas Pharma US, Inc.
  • Bayer Healthcare Pharmaceuticals, Inc.
  • Janssen Pharmaceuticals, Inc.
  • Pfizer, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English
  • Spanish
Cleveland Clinic Mobile Site